-
Something wrong with this record ?
Potential anticlastogenic effect of hyperforin
Petronela Imreova, Eva Miadokova, Eliska Galova, Stephka Chankova, Ivan Chalupa
Language English Country Czech Republic
Document type Review, Research Support, Non-U.S. Gov't
Digital library NLK
Source
NLK
ROAD: Directory of Open Access Scholarly Resources
from 2011
- MeSH
- Antidepressive Agents therapeutic use toxicity MeSH
- Anti-Inflammatory Agents therapeutic use toxicity MeSH
- Antimutagenic Agents therapeutic use toxicity MeSH
- Benzopyrenes * chemistry MeSH
- Biomedical Research MeSH
- Cell Line cytology drug effects MeSH
- Hep G2 Cells cytology drug effects MeSH
- Chromosome Aberrations * chemically induced drug effects MeSH
- Humans MeSH
- Statistics as Topic MeSH
- Hypericum * chemistry MeSH
- Check Tag
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Hyperforin is a prenylated phloroglucinol derivative which occurs in the plant Hypericum perforatum L. It has several medicinally important properties (antidepressant, anti-inflammatory, proapoptotic, antibacterial and antiangiogenic). To enable its medicinal use, it is necessary to investigate its potential genotoxic effect on human cell lines. We also observed an anticlastogenic effect of hyperforin towards the indirect mutagen benzo(a)pyrene. Benzo(a)pyrene is a widespread polycyclic aromatic hydrocarbon. We performed experiments on human tumor cell line HepG2, using the in vitro mammalian chromosome aberration test. We investigated two cytogenic parameters: the number of aberrant metaphases and the total number of chromosome aberrations. We found out that hyperforin was not genotoxic on human cell line HepG2. The second part of our results implies that hyperforin had an anticlastogenic effect against the indirect mutagen benzo(a)pyrene in our experimental conditions. In future we will continue our research by using another range of hyperforin concentrations, other cell lines and other chemical mutagens.
Department of Genetics Faculty of Sciences Comenius University Bratislava
Institute of Biodiversity and Ecosystem Researches Bulgarian Acad Sci Sofia Bulgaria
Institute of Experimental Oncology Slovak Academy of Sciences Bratislava
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14057789
- 003
- CZ-PrNML
- 005
- 20140623113659.0
- 007
- ta
- 008
- 140507s2013 xr ad f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.31482/mmsl.2013.028 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Imreová, Petronela $7 _AN077851 $u Department of Genetics, Faculty of Sciences, Comenius University, Bratislava
- 245 10
- $a Potential anticlastogenic effect of hyperforin / $c Petronela Imreova, Eva Miadokova, Eliska Galova, Stephka Chankova, Ivan Chalupa
- 504 __
- $a Literatura
- 520 9_
- $a Hyperforin is a prenylated phloroglucinol derivative which occurs in the plant Hypericum perforatum L. It has several medicinally important properties (antidepressant, anti-inflammatory, proapoptotic, antibacterial and antiangiogenic). To enable its medicinal use, it is necessary to investigate its potential genotoxic effect on human cell lines. We also observed an anticlastogenic effect of hyperforin towards the indirect mutagen benzo(a)pyrene. Benzo(a)pyrene is a widespread polycyclic aromatic hydrocarbon. We performed experiments on human tumor cell line HepG2, using the in vitro mammalian chromosome aberration test. We investigated two cytogenic parameters: the number of aberrant metaphases and the total number of chromosome aberrations. We found out that hyperforin was not genotoxic on human cell line HepG2. The second part of our results implies that hyperforin had an anticlastogenic effect against the indirect mutagen benzo(a)pyrene in our experimental conditions. In future we will continue our research by using another range of hyperforin concentrations, other cell lines and other chemical mutagens.
- 650 12
- $a třezalka $x chemie $7 D020902
- 650 12
- $a benzopyreny $x chemie $7 D001580
- 650 _2
- $a antimutagenní látky $x terapeutické užití $x toxicita $7 D016587
- 650 _2
- $a antidepresiva $x terapeutické užití $x toxicita $7 D000928
- 650 _2
- $a antiflogistika $x terapeutické užití $x toxicita $7 D000893
- 650 12
- $a chromozomální aberace $x chemicky indukované $x účinky léků $7 D002869
- 650 _2
- $a buňky Hep G2 $x cytologie $x účinky léků $7 D056945
- 650 _2
- $a buněčné linie $x cytologie $x účinky léků $7 D002460
- 650 _2
- $a biomedicínský výzkum $7 D035843
- 650 _2
- $a statistika jako téma $7 D013223
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Miadoková, Eva, $d 1946- $7 xx0104462 $u Department of Genetics, Faculty of Sciences, Comenius University, Bratislava
- 700 1_
- $a Galová, Eliška $7 _AN077852 $u Department of Genetics, Faculty of Sciences, Comenius University, Bratislava
- 700 1_
- $a Chankova, Stephka $u Institute of Biodiversity and Ecosystem Researches, Bulgarian Acad. Sci., Sofia, Bulgaria
- 700 1_
- $a Chalupa, Ivan $7 _AN043166 $u Institute of Experimental Oncology, Slovak Academy of Sciences, Bratislava
- 773 0_
- $t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 82, č. 4 (2013), s. 180-184 $w MED00011116
- 856 41
- $u http://www.mmsl.cz/archive/2013 $y domovská stránka časopisu - plný text volně přístupný
- 910 __
- $a ABA008 $b A 3 $c 1073 $y 4 $z 0
- 990 __
- $a 20140128155441 $b ABA008
- 991 __
- $a 20140623113930 $b ABA008
- 999 __
- $a ok $b bmc $g 1024641 $s 856397
- BAS __
- $a 3
- BMC __
- $a 2013 $b 82 $c 4 $d 180-184 $i 0372-7025 $m Vojenské zdravotnické listy $n Vojen. zdr. listy $x MED00011116
- LZP __
- $c NLK184 $d 20140623 $a NLK 2014-23/dk